Table 3.

Prevalence of moderate-to-severe symptom burden as assessed with ESAS (score 4–10) or EQ-5D-5L (score moderate or worse).

	Non-Expandable Lung n = 12	Expandable Lung n = 31	p-Value
ESAS	n = 12	n = 31
Pain, n (%)	3 (25%)	12 (39%)	0.49
Tiredness, n (%)	6 (50%)	21 (68%)	0.31
Nausea, n (%)	1 (8%)	8 (26%)	0.40
Drowsiness, n (%)	4 (33%)	15 (48%)	0.50
Appetite, n (%)	4 (33%)	19 (61%)	0.17
Dyspnoea, n (%)	9 (75%)	25 (81%)	0.69
Depression, n (%)	4 (33%)	13 (42%)	0.73
Anxiety, n (%)	4 (33%)	13 (45%)	0.73
Wellbeing, n (%)	5 (42%)	21 (68%)	0.17
EQ-5D-5L
Mobility, n (%)	3 (23%)	18 (53%)	0.065
Self-care, n (%)	1 (8%)	12 (35%)	0.058
Usual Activities, n (%)	8 (62%)	25 (71%)	0.51
Pain/discomfort, n (%)	7 (54%)	14 (41%)	0.43
Anxiety/depression, n (%)	3 (23%)	9 (26%)	0.85
Health, mean VAS score (SD)	64 (28)	58 (26)	0.49
Combined utility score (IQR)	0.836 (0.691–0.906)	0.806 (0.409–0.866)	0.37